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For purposes of gene therapy, the tropism of adenovirus (Ad) serotype 5 vectors can be altered with fibers derived from alternative
serotypes. However, there is currently limited information available on the cellular receptors used by the approximately 51 known Ad
serotypes. Recently, a(2!3)-linked sialic acid (2,3-SA) has been implicated as the cellular receptor for wild-type Ad37. However, some
studies have demonstrated that wild-type Ad37 uses a 50-kDa protein and not sialic acid as its primary receptor for binding of human
conjunctival cells. The sialic acid receptor has also been shown not to play a major role in the infection of these cells by an Ad5 virion
pseudotyped with Ad37 fiber (Ad5.GFP.DF/37F). In this study, we demonstrate that a similar virus (Ad5F37) can indeed use a(2!3)-linked
sialic acid as a cellular receptor. We also find that the receptor used by Ad5F37 is sensitive to proteases and that Ad5F37 can use integrin
more efficiently than sialic acid for cell entry. Unlike Ad5 vectors, Ad5F37 does not efficiently employ the coxsackie and adenovirus receptor
(CAR) to infect cells. Similar to Ad5, Ad5F37 infection of cells that form tight junctions can be enhanced by ethylenediaminetetraacetic acid
(EDTA). These results have implications in the design of pseudotyped adenovirus vectors for gene therapy and may have particular use in the
treatment of diseases involving breakdown of the blood–retinal barrier.
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Adenovirus (Ad) is the vector of choice in many gene
therapy applications. The majority of gene therapy studies
utilizing Ad have used serotypes 2 and 5. The tropism of both
of these Ads is determined by the binding of the knob domain
of the fiber protein to the coxsackie virus and adenovirus
receptor (CAR) (Bergelson et al., 1997), a transmembrane
protein of the tight junction (Cohen et al., 2001). Intravenous
injection of recombinant Ad2 or Ad5 in rodents results in
rapid uptake by the liver (Alemany and Curiel, 2001), and
ablation of CAR binding is generally insufficient to alter Ad
tropism (Einfeld et al., 2001). To enhance the utility of Ad in
gene therapy applications, there has been considerable inter-
est in redirecting Ad5 tropism by pseudotyping Ad5 with0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: rkumar@hmbg.utah.edu (R. Kumar-Singh).fibers from Ads of alternative serotypes (Einfeld and Roel-
vink, 2002). However, little is known about the cellular
receptors used by the approximately 51 other known Ad
serotypes (De Jong et al., 1999; Shenk, 1995). Recently, it has
been shown that certain group D viruses including Ad37 use
sialic acid as a cellular receptor to gain entry into a variety of
cell types including ovarian (CHO), lung epithelial (A549),
and human conjunctival (Chang C), and that the sialic acid
binding is mediated by the knob domain of the fiber (Arnberg
et al., 2000a, 2000b, 2002). In contrast, some studies have
determined that wild-type Ad37 binds Chang C cells using a
neuraminidase-insensitive 50-kDa membrane protein (Wu et
al., 2001) and that an Ad5 virus pseudotyped with an Ad37
fiber (Ad5.GFP.DF/37F) infects Chang C cells using a sialic
acid-independent pathway. These same authors also deter-
mined that cell and tissue tropism of Ad5.GFP.DF/37F
vectors is substantially altered relative to Ad5 viruses (Von
Seggern et al., 2003). In the context of gene therapy, the issue
of which receptor is utilized by a pseudotyped Ad5F37 is of
significant interest. The majority of previous studies where
the tropism of pseudotypedAd vectors was studied were done
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virus, resulting in important gaps in our knowledge on the
behavior of pseudotyped Ad vectors. Identification of sialic
acid as a potential receptor for Ad37 allows for better
characterization of the altered tropism of Ads pseudotyped
by Ad37 fibers. In contrast to previously published studies,
here we show that akin to Ad37, Ad5F37 also uses a(2!3)-
linked sialic acid (2,3-SA) as a cellular receptor. Infection of
cells by Ad5F37 is sensitive to proteases and Ad5F37 can use
integrin alone to infect cells more efficiently than a(2!3)-
linked sialic acid alone. Similar to wild-type Ad37, Ad5F37
does not use CAR for infection of cells. Finally, we show that
like Ad5, Ad5F37 infection of cells that form tight junctions
can be enhanced by ethylenediaminetetraacetic acid (EDTA).Fig. 1. Structure of EGFPNAd5f37 (A). The hybrid fiber is composed of the
first 10 amino acids of Ad5 followed by amino acids 11–365 of wild-type
Ad37 (aa 11–17 of Ad5 and Ad37 are identical). The fusion fiber is
followed by 63 bp of Ad37 DNA containing a poly A signal that is further
followed by a bovine growth hormone polyadenylation signal (BGH pA).
Ad5 nucleotides 32744–32787 were retained to ensure proper functioning
of the E4 genes. An EGFP expression cassette was cloned in the antisense
orientation (with respect to the E1 enhancer) into the E1 region of an
E1lE3-deleted Ad5 virus. N terminal amino acid sequence of wild-type
Ad5, wild-type Ad37, and the fusion fiber of EGFPNAd5f37 (B). Western
analysis of denatured and native fiber proteins from EGFPNAd5 (expected
products 65, 130, and 195 KDa for monomer, dimer, and trimer,
respectively) and EGFPNAd5F37 (expected products 40 and 120 kDa for
monomer and trimer, respectively) using a monoclonal antibody specific for
the N-terminal amino acids of Ad2–Ad5 (C). ITR, adenovirus inverted
terminal repeat;C, Ad packaging signal; MLT, major late transcription unit;
E, early region; CMV, cytomegalovirus promoter/enhancer.Results
Pseudotyping of Ad5 with Ad37 fiber
To determine whether Ad5 tropism could be redirected
from CAR to sialic acid, we modified the Ad5 genome
(Fig. 1A) cloned in pAdEasy1 (He et al., 1998) such that
the gene encoding Ad5 fiber was instead expressing a
fusion fiber consisting of the N terminal 10 amino acids
unique to Ad5 fiber, followed by the amino acids
FNPVYPY that are common to both Ad5 and Ad37
fiber (amino acids 11–17 of Ad5 or Ad37 fiber),
followed by amino acids 18–365 of Ad37 fiber (Fig.
1B). The ‘fusion’ fiber was polyadenylated by a BGH pA
signal in addition to the native Ad5 fiber poly A signal,
which was retained to ensure a potent pA signal down-
stream of the fusion fiber in addition to reducing the
possibility of deleteriously affecting any transcripts on the
antisense strand. To examine cell entry and expression of
viral genes, an expression cassette encoding enhanced
GFP (EGFP) regulated by a cytomegalovirus (CMV)
promoter was inserted into the (deleted) E1 region of
the pseudotyped virus EGFPNAd5F37. A similar expres-
sion cassette was cloned into the parental control Ad5
virus EGFPNAd5 (Fig. 1A). To confirm expression and
translation of the fusion fiber, we infected 911 cells with
each virus and probed the fiber protein using a mono-
clonal antibody generated against the N-terminal region
of Ad2–Ad5. As predicted by sequence analysis, we
observed protein products consistent with denatured
wild-type Ad5 fiber of 65 kDa in cells infected with
EGFPNAd5 and a shorter 40-kDa product consistent with
the predicted amino acid sequence of the EGFPNAd5F37
fiber. Trimerization (and dimerization in the case of
EGFPNAd5) of fibers from each virus was also detected
in samples that were not boiled before Western analysis
(Fig. 1C). Expression of EGFP from the transgene of
each virus was confirmed by infection of 911 cells and
visualization using a GFP fluorescence microscope (data
not shown).
Fig. 2. FACS analyses of a(2! 3)-linked sialic acid expression on Chang
C and A549 cells (A). FITC, cells incubated with FITC-conjugated
streptavidin; Mal II, cells incubated with biotinylated Mal II; Mal II–FITC,
cells incubated with both biotinylated Mal II and FITC-conjugated
streptavidin. FACS analyses Chang C or A549 cells infected by
EGFPNAd5F37 and EGFPNAd5 after treatment with (+) and without
( ) neuraminidase (Neu) or maackia amurensis lectin (Mal II) (B). For
Chang C cells, curves representing FITC and Mal II overlap substantially.
Fig. 3. FACS analyses of EGFPNAd5F37 or EGFPNAd5-infected Chang C
or A549 cells pretreated with Proteinase K (ProK) or Bromelain (Brom).
Chang C cells were more sensitive to protease treatment than A549 cells
and therefore were incubated for a shorter period (30 min) instead of that
used for A549 cells (1 h). This may account for higher infection rates of
Chang C cells in these experiments. No protease-induced damage to cells
was observed, as measured by exclusion of propidium iodide.
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infection
In some previous studies, wild-type Ad37 was shown to
specifically bind a(2!3)-linked sialic acid (2,3-SA) (Arn-
berg et al., 2000a). Sialic acid was shown to be involved
in Ad37 entry by observing that pretreatment of Chang C
or A549 cells with Vibrio cholerae neuraminidase signif-
icantly reduces wild-type Ad37 binding (Arnberg et al.,
2000b, 2002). In addition, Ad37 binding can be signifi-
cantly reduced by pre-incubation of cells with the 2,3-SA
binding maackia amurensis lectin Mal II (Arnberg et al.,
2000a). To determine if EGFPNAd5F37 can also use sialic
acid as a cellular receptor, we investigated infection of
Chang C and A549 cells by EGFPNAd5F37 or EGFP-
NAd5. Before infection, we first confirmed that both celltypes were expressing 2,3-SA by measuring their ability to
bind Mal II (Fig. 2A). We then blocked cell surface 2,3-SA
with Mal II or removed sialic acid by exposure of cells to
Vibrio cholerae neuraminidase before infection with each
virus. We found that whereas prior exposure of Chang C
or A549 cells to neuraminidase had no significant effect on
EGFPNAd5 infection, EGFPNAd5F37 infection was re-
duced by 60 F 0.5% and 37 F 1.2% in Chang C and
A549 cells, respectively. Similarly, prior treatment of cells
with Mal II had no significant effect on EGFPNAd5
infection, whereas infection by EGFPNAd5F37 was re-
duced by 26 F 3.6% and 60 F 3.2% in Chang C and
A549 cells, respectively (Fig. 2B). Of note is that Wu et al.
(2001) observed an approximately 16-fold greater infection
of Chang C cells relative to A549 by a virus very similar
S.M. Cashman et al. / Virology 324 (2004) 129–139132to EGFPNAd5F37, whereas we found a difference of
approximately 1.2- to 1.4-fold greater infection of A549
relative to Chang C (Fig. 2B). Nonetheless, our results are
consistent with the hypothesis that EGFPNAd5F37 uses
2,3-SA as a cellular receptor because these two cell lines
have comparable amounts of sialic acid (Fig. 2A).
EGFPNAd5f37 receptor is sensitive to proteases
Previously, it has been shown that wild-type Ad37
binding of Chang C (Wu et al., 2001) and CHO cells
(Arnberg et al., 2000a) is reduced when those cells are
pretreated with general or specific proteases. To determine
if this property is also conferred upon EGFPNAd5F37, we
infected Chang C or A549 cells that had been pretreated
with the broad spectrum (Ebeling et al., 1974) serine
protease, Proteinase K, or the more specific (Rowan et
al., 1990) cysteine protease Bromelain. Similar to previous
results obtained with wild-type Ad37, EGFPNAd5F37 had
reduced infectivity of cells that had been pretreated with
either protease (Fig. 3), although the effect, at least for
Bromelain, was more significant in Chang C than A549
cells (P < 0.03). In addition, infection by EGFPNAd5F37
was more significantly reduced relative to that of EGFP-
NAd5. Specifically, the control virus EGFPNAd5 that is
known to bind the transmembrane receptor protein CAR
was reduced by 36.6 F 0.6% and 26.4 F 1.3% in Chang
C and A549 cells, respectively, with Proteinase K treat-Fig. 4. Western analysis of aV integrin expression by A549, Chang C, RPE-J, Y79
and Y79 cells (B). Infection of Y79 and Lec2 cells by EGFPNAd5F37 and EGFP
FITC, cells incubated with FITC-conjugated streptavidin; Mal II, cells incubated w
Mal II and FITC-conjugated streptavidin.ment and 19.9 F 5.4% and 5.9 F 1.8% in Chang C and
A549 cells, respectively, with Bromelain. In contrast,
EGFPNAd5F37 was reduced by 50 F 1.4% and 38.2 F
2.3% in Chang C and A549 cells, respectively, with
Proteinase K treatment and 26.8 F 1.8% and 10 F
2.5% in Chang C and A549 cells, respectively, with
Bromelain (Fig. 3). These data are consistent with the
hypothesis that the sialic acid used by EGFPNAd5F37 is
present on glycoproteins as previously shown for wild-type
Ad37 (Arnberg et al., 2000a).
Role of CAR, integrin, and sialic acid in EGFPNAd5F37
and EGFPNAd5 infection
Ablation of either CAR or integrin binding by Ad5 has
been previously shown to reduce infectivity of AE25 cells
10-fold (Einfeld et al., 2001). The biodistribution of an
intravenously injected Ad is not significantly affected by
ablation of CAR binding, and more than 75% of the
remaining infectivity has been attributed to the penton
base: integrin interaction (Alemany and Curiel, 2001).
Many different Ad serotypes use aV integrins for cell
entry via receptor-mediated endocytosis following attach-
ment to their receptor (Mathias et al., 1994). A role for aV
integrin has been implicated in infection by Ad37 (Arnberg
et al., 2000b), and it has been shown that Ad37 binds
aVh5 integrin with an approximately 2-fold greater effi-
ciency than Ad5 (Mathias et al., 1998), possibly indicating, and Lec2 cells (A). FACS analyses of a(2! 3)-linked sialic acid by Lec2
NAd5 (C). FACS analyses of CAR expression by Y79 and Lec2 cells (D).
ith biotinylated Mal II; Mal II–FITC, cells incubated with both biotinylated
Fig. 5. FACS analyses of Lec 2 cells transfected with hCAR or LacZ-
expressing plasmid followed by infection with EGFPNAd5F37 or
EGFPNAd5. Mean fluorescence was calculated as the mean fluorescence
achieved with plasmid transfection followed with viral infection, less mean
fluorescence of cells associated with plasmid transfection alone (A). The
percentage increase in EGFP-positive cells when transfected with hCAR
and subsequently infected with either EGFPNAd5F37 or EGFPNAd5
relative to LacZ-transfected cells infected with either virus is also presented
(B). Fluorescence microscopy of Lec 2 cells transfected with hCAR or
LacZ followed by infection with EGFPNAd5F37 or EGFPNAd5 (C).
Original magnification was  200.
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uptake than Ad5. In addition, Ad5.GFP.DF/37F infection
of Chang C cells can be reduced approximately 2.8-fold if
the cells are pretreated with an aV integrin-blocking
antibody (Chiu et al., 2001). To generally examine the
relative role of aV integrin in EGFPNAd5F37 and EGFP-
NAd5 infection, we determined aV expression in five
different cell lines. Specifically, we tested Chang C,
A549, RPE-J, Y79, and CHO (Lec2). All cell lines except
the retinoblastoma cell line Y79 were determined to
express aV integrin (Fig. 4A). Y79 cells did however
express 2,3-SA (Fig. 4B). To determine the relative effi-
ciencies of EGFPNAd5F37 and EGFPNAd5 for their
primary receptors, 2,3-SA and CAR, respectively, we used
the CHO subline, Lec2. Lec2 has previously been shown
to express a reduced amount of sialic acid by measuring its
ability to bind wheat germ agglutinin (WGA) (Arnberg et
al., 2000a). We examined whether cell surface 2,3-SA was
specifically reduced on Lec2 and Y79 cells by measuring
binding of Mal II (Fig. 4B) by these cells. We also
determined the expression of CAR on these cells by flow
cytometry. We found that Lec 2 cells did not express
significant amounts of CAR, but Y79 cells did express
CAR (Fig. 4D). Because we determined that Lec 2 cells do
express aV integrin but not CAR or 2,3-SA, we were able
to utilize these cells to determine the relative efficiencies
of EGFPNAd5F37 and EGFPNAd5 for their primary
receptors. We found that EGFPNAd5 infects both Y79
and Lec2 cells more efficiently (at least 50- and 35-fold,
respectively) than EGFPNAd5F37 (Fig. 4C), consistent
with the more efficient use of both moieties by this virus.
A multiplicity of infection (MOI) of 48000 (4-fold higher
than that used in Lec2 cells) resulted in observable
infection of Y79 cells, indicating the ability of EGFP-
NAd5F37 to use sialic acid alone to infect cells albeit
much less efficiently than integrin alone. These data are
also consistent with the hypothesis that in the case of
EGFPNAd5, CAR plays a greater role than aV integrin in
cell entry. However, as EGFPNAd5 does infect CAR-
deficient Lec 2 cells, the role of CAR relative to aV
integrin should not be overstated.
EGFPNAd5F37 cannot use CAR to efficiently infect cells
Previously, it has been shown that the knob domain of
wild-type Ad37 fiber can bind CAR (Wu et al., 2001). In
addition, the Ad5 fiber knob significantly blocks Ad37
binding toA549 cells, raising the possibility that these viruses
may share cellular receptors (Wu et al., 2003). Ad37 fiber has
a sequence similar to the CAR-binding site of Ad5 fiber
(Bewley et al., 1999). CAR has also been shown to be
efficiently used by an Ad2 virus pseudotyped with the
subgenus D, Ad17 fiber (Zabner et al., 1999). Given that
wild-type Ad37 fiber can bind CAR, we wished to determine
whether EGFPNAd5F37 might also potentially use CAR as a
cellular receptor. CHO cells lack significant expression ofCAR (Shayakhmetov et al., 2000), which we confirmed also
true for the CHO subline Lec2 (Fig. 4B).When CHO cells are
stably transfected with a plasmid expressing CAR, Ad5
binding increases approximately 24-fold (Arnberg et al.,
2000a). Because Lec 2 cells also do not express CAR, we
examined the ability of EGFPNAd5F37 to infect Lec 2 cells
that had been transfected with a plasmid expressing human
CAR (hCAR). Using electroporation, we were able to con-
sistently transfect 40% of Lec 2 cells with either a plasmid
expressing LacZ or CAR (data not shown). Under these
conditions, we found that EGFPNAd5 infection was not only
increased by 13.3 F 0.96% in cells transiently transfected
with CAR relative to LacZ (Fig. 5B), but also that EGFP-
NAd5-infected CAR-expressing cells had a 2.4-fold increase
in GFP (Figs. 5A and 5C) expression. Although the number
of CAR-transfected cells infected by EGFPNAd5F37 in-
creased by 5.6 F 1.39% (Fig. 5B) relative to LacZ-trans-
fected cells, these cells showed no increase in levels of GFP
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mean fluorescence of approximately 40, that is, 8-fold less
than the total mean fluorescence of cells. These data are
consistent with the hypothesis that EGFPNAd5 is able to use
CAR as a cellular receptor (as previously shown), but use of
CAR by EGFPNAd5F37 is not efficient.
EDTA enhances infection of RPE-J cells by EGFPNAd5F37
Disruption of tight junctions with EDTA has been
previously shown to enhance infection of polarized tra-
cheobronchial epithelial cells by recombinant Ad5 viruses
by increasing accessibility of CAR sequestered in these
junctions (Cohen et al., 2001). The retinal pigment epithe-
lium is involved in the formation and maintenance of the
outer blood–retinal barrier (Cunha-Vaz, 1979). RPE-J is a
rat retinal pigment epithelial cell line that exhibits cell
surface polarity in vitro, as well as circumferential staining
for the tight junction protein, ZO-1 (Nabi et al., 1993). We
confirmed the expression of 2,3-SA, aV integrin, and CAR
by RPE-J cells (Figs. 4A and 6A). In addition, we
observed the sialic acid-binding lectin wheat germ agglu-
tinin (WGA) to stain predominantly at points of cell to cell
contact (Fig. 6B), similar to previously reported expression
patterns for ZO-1 and CAR (Cohen et al., 2001). We tested
the ability of EGFPNAd5F37 and EGFPNAd5 to infect
RPE-J cells that had their tight junctions disrupted by
EDTA. We determined that use of 2.5 mM EDTA was
sufficient to observe an increase in infection of 61.4 F
1.1% and 50.9 F 7.0% by EGFPNAd5F37 and EGFP-Fig. 6. FACS analyses of CAR and a(2! 3)-linked sialic acid expression by R
binding to RPE-J cells (B). Original magnification was  400. FACS analyses of
(+) and without ( ) EDTA (C).NAd5, respectively (Fig. 6C). In previous studies, pretreat-
ment of Chang C cells with 10 mM EDTA has been
shown to completely ablate binding by wild-type Ad37
(Wu et al., 2001). However, in some other studies, the
same concentration of EDTA has been reported to have no
effect on binding of wild-type Ad37 (Arnberg et al., 2002).Discussion
Our studies are consistent with the following six con-
clusions. First, a genetically functional hybrid fiber can be
generated composed of Ad5 fiber amino acids 1–10 fused
to Ad37 fiber amino acids 11–365. Our approach at
pseudotyping Ad5 with Ad37 fiber differs from previous
studies (Wu et al., 2001). Whereas we replaced the gene
coding for Ad5 with Ad5F37, in previous studies the
Ad5F37 fusion fiber was provided in trans to fiberless
particles in a stable cell line. Genetic replacement of the
Ad5 fiber has some advantages over providing the fusion
fiber in trans. Because the fusion fiber in our study is under
control of the native major late promoter, we expect the
fusion fiber to be expressed at similar levels to the native
Ad5 fiber. This is unlikely to be the case when fiber is
expressed from a CMV promoter in trans. Hence, it is likely
that the pseudotyped virus described here is not deficient or
limited for fiber incorporation. Our fiber fusion also differs
from previous studies (Wu et al., 2001) in that our cloning
strategy resulted in the amino acid threonine at position 10,
whereas in previous studies this amino acid was asparticPE-J cells (A). Fluorescent microscopy of wheat germ agglutinin (WGA)
EGFPNAd5F37- and EGFPNAd5-infected RPE-J cells after treatment with
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binding to the 50-kDa receptor on Chang C cells (Huang et
al., 1999; Wu et al., 2001), this difference is not of
significant concern in the context of comparing our results
with previous studies. For purposes of gene therapy, incor-
poration of an expression cassette coding for EGFP allowed
us to study expression of transgenes postinfection rather
than Ad binding alone, as has been the main focus of
previous studies involving Ad37.
Second, we have shown that the tropism of Ad37 fiber
for sialic acid can be conferred upon Ad5 by fiber
pseudotyping. Specifically, we demonstrated that Chang
C and A549 cells express 2,3-SA and that EGFP-
NAd5F37 can use 2,3-SA to infect both of these cell
types. We reached this conclusion by the observation that
infection of Chang C and A549 cells by EGFPNAd5F37
is significantly reduced if the cells are pretreated with the
sialic acid hydrolyzing enzyme neuraminidase or with the
sialic acid binding lectin Mal II. Mal II treatment of
Chang C or A549 cells had no significant effect on
infection by EGFPNAd5. The increased infection of
neuraminidase-treated A549 cells by EGFPNAd5 (6.6 F
2.5%) has also been observed previously (Arnberg et al.,
2000a, 2002). We conclude that exchanging the fiber of
Ad5 with Ad37 is sufficient to redirect tropism from
CAR to sialic acid for infection of Chang C and A549
cells. In the case of EGFPNAd5F37 infection of Chang C
cells, treatment with neuraminidase had a more signifi-
cant effect than blocking with Mal II (60% and 26%,
respectively). In contrast, EGFPNAd5F37 infection of
A549 cells was more reduced by Mal II than by
neuraminidase—60% and 37%, respectively. The Chang
C result could be explained by the fact that neuramini-
dase digests at least two different sialic acid linkages
(Rogerieux et al., 1993), whereas Mal II preferentially
blocks 2,3-SA—implicating use of other sialic acid link-
ages in addition to 2,3-SA by EGFPNAd5F37 for cell
entry. The A549 result would suggest that infection of
these cells by EGFPNAd5F37 is more dependent upon
2,3-SA than other types of sialic acid or that A549 cells
express more 2,3-SA than other types of sialic acid. The
effect of maackia amurensis agglutinin (MAA) on the
binding of wild-type Ad37 was less than that of WGA
(Arnberg et al., 2000a, 2002), arguing in favor of the use
of other sialoconjugates, in addition to 2,3-SA. Sendai
virus and influenza virus, for example, can use both 2,3-
SA and 2,6-SA, albeit at different efficiencies (Stephen-
son et al., 2003; Suzuki et al., 2001). While studies
involving wild-type Ad37 have demonstrated almost
complete ablation of infection by neuraminidase, we did
not observe this to be the case for EGFPNAd5F37
despite using approximately three times more neuramin-
idase than Arnberg et al. (2000a, 2002). This suggests
that sialic acid may not be the only type of receptor used
by EGFPNAd5F37. This has already been indicated for a
similar Ad5.GFP.DF/37F that exhibits only a 20% reduc-tion in infection of Chang C cells pretreated with 4-fold
more neuraminidase than Wu et al. (2001). The signifi-
cant role observed by us for integrin in cellular uptake of
EGFPNAd5F37 could be sufficient to explain the residual
infection post neuraminidase or Mal II treatment.
Third, we conclude that at least one of the receptors
used by EGFPNAd5F37 is associated with proteins on the
cell surface, as it is sensitive to protease treatment. Binding
of wild-type Ad37 to cells has been observed to be
sensitive to a variety of different proteases, including
Proteinase K and Bromelain (Arnberg et al., 2000a; Wu
et al., 2001). While Arnberg et al. (2000a) argued that this
is due to the presence of the sialic acid used by Ad37 on
glycoproteins as opposed to glycolipids, Wu et al. (2001)
argued in favor of Ad37 binding to a neuraminidase-
insensitive 50-kDa protein receptor in Chang C cells. As
we did not observe complete ablation of EGFPNAd5F37
infection by neuraminidase despite the use of significantly
greater amounts of enzyme than previously used, we
cannot rule out the possibility that EGFPNAd5F37 also
uses a non-sialic acid protein receptor. However, as stated
previously, we believe that incomplete ablation of infection
could be reasonably explained by use of integrin by the
virus to gain cell entry. It is curious, however, that
bromelain treatment exerted a greater effect on Chang C
than A549 cells; binding of Ad37 to the 50-kDa receptor
was not observed in A549 cells.
Fourth, we conclude that EGFPNAd5F37 uses both
integrin and 2,3-SA alone less efficiently for infection
than EGFPNAd5 uses integrin and CAR alone. That the
pseudotyped EGFPNAd5F37 virus should infect cells less
efficiently than the parental EGFPNAd5 virus is expected;
an Ad5 virus modified to contain the Ad35 fiber knob
domain has been shown to follow a different intracellular
trafficking pathway and a significant number of the pseu-
dotyped particles are recycled back to the cell surface
(Shayakhmetov et al., 2003). In addition, Zabner et al.
(1999) have shown a greater than 5-fold difference in
infectivity of a fiber 17-pseudotyped Ad2 virus when
compared with Ad2, and that this difference can be
eliminated using methods that overcome the requirements
for a fiber receptor. Although integrin is expressed at very
low levels in CHO cells (Shayakhmetov et al., 2000), we
found Lec2, which is a subline of CHO, to express aV
integrin at levels equivalent to all other cell types used in
this study (Fig. 4A). This sialic acid-deficient cell line is
infected more efficiently by EGFPNAd5F37 than Y79
cells, suggesting that integrin plays a greater role than
2,3-SA in cell entry of EGFPNAd5F37. It is likely that the
use of integrin by EGFPNAd5F37 is sufficient to explain
the incomplete ablation of infection by neuraminidase or
Mal II.
Fifth, we conclude that EGFPNAd5F37 cannot use
CAR efficiently to infect cells. Wu et al. (2001) have
observed the ability of the Ad37 fiber knob to bind CAR
immobilized on a PVDF membrane, although infection of
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inhibited by a CAR-blocking antibody. Hence, it is not
surprising that we see a small increase in infection of cells
that have been transfected by a CAR-expressing plasmid.
The Ad5 knob can significantly (approximately 60%)
block binding of Ad37 to A549 cells, although CAR
binding by Ad37 is inefficient due to the short length of
the Ad37 fiber (Wu et al., 2003). A hybrid fiber similar to
that of EGFPNAd5F37 has been shown to mediate infec-
tion of CAR-transfected CHO cells by an Ad2 virus
containing fiber knob sequences of Ad17 (Zabner et al.,
1999). We observed reasonable levels of Lec2 infection by
EGFPNAd5 even in the absence of CAR transfection.
Although using an antibody to detect human CAR leads
us to the conclusion that Lec2 cells are CAR-deficient, this
observation may be erroneous if there is no cross-reactivity
between the antihuman CAR antibody and Chinese ham-
ster CAR. Previous studies also did not observe CAR
expression on CHO cells, but they also used an antibody
against human CAR (Shayakhmetov et al., 2000). We did,
however, observe cross-reactivity with rat CAR in RPE-J
cells (Fig. 6A).
Sixth, we conclude that disruption of tight junctions
between RPE-J cells enhances EGFPNAd5F37 infection.
EDTA has been shown to increase permeability of tight
junctions in cultured rat RPE cells (Rezai et al., 1997).
Because experiments described above indicate that EGFP-
NAd5F37 uses 2,3-SA and not CAR to gain cell entry and
that both CAR and SA are expressed on RPE-J cells, it is
likely that EGFPNAd5F37 has enhanced access to the
sialic acid post disruption of the tight junctions. EDTA
enhancement of adenovirus serotype 5 infection has pre-
viously been observed in a polarized tracheobronchial
epithelial cell line, in which CAR is expressed in associ-
ation with the tight junction protein ZO-1 (Cohen et al.,
2001). The circumferential distribution of sialic acid
(WGA staining; Fig. 6B) suggests that as for Ad5 binding
of CAR, treatment with EDTA possibly increases accessi-
bility of sialic acid for binding by EGFPNAd5F37. This
observation may have significance in the treatment of
diseases such as diabetic retinopathy, which is the leading
cause of blindness in middle-aged and older people (Javitt
et al., 1994). Specifically, the most common cause of
vision loss in diabetes is due to macular edema (Moss et
al., 1998), a pathology that results as a direct consequence
of blood–retinal barrier breakdown. Increased susceptibil-
ity of RPE by EGFPNAd5F37 during tight junction
disruption may offer a potential advantage to deliver
therapeutic transgenes to the RPE using Ad5F37 vectors.
While we have demonstrated the significant role of sialic
acid in infection by EGFPNAd5F37, we have not excluded a
role for the 50-kDa receptor. However, it should be noted that
whereas Wu et al. (2001) determined that Ad37 binds the 50-
kDa receptor in an overlay blot assay, CARwas also shown to
bind Ad37 in this same experiment. However, CAR has been
shown independently not to be used by Ad37 for infection ofcells in culture (Arnberg et al., 2000a; Wu et al., 2001, 2003).
Hence, it is possible that similar observations might be made
for the 50-kDa receptor in future studies.
In summary, we have shown that it is possible to
genetically pseudotype Ad5 with the Ad37 fiber. Al-
though the resulting virus uses 2,3-SA as a cellular
receptor, this may not be the only receptor the virus
can use. Although infection of cells is sensitive to
protease treatment, the alternate receptor(s) used by
EGFPNAd5F37 does not include CAR. When present
alone, integrin is more efficient than SA for entry of
EGFPNAd5F37. Infection can be enhanced by exposure
of sialic acid at tight junctions by EDTA. These data
have relevance for the further design of Ad vectors for
gene therapy and possible use in the treatment of diseases
involving the blood–retinal barrier.Materials and methods
Recombinant adenovirus constructs
Ad5 virus expressing Ad37 fiber was generated via
genetic modification of the Ad5 genome cloned in
pAdEasy-1 (He et al., 1998). In brief, pAdEasy-1 was
digested with SpeI and PacI, and the 6211-bp fragment
containing the fiber gene was cloned into pBSx (Cox et al.,
1993), resulting in p6.2FIB. Ad5 nt 32744–32872were PCR
amplified using primers Ad32744F (cccaagcttgccacatcctctta-
cac) and Ad32872R (tggggctatactactgaatg), yielding a 128-
bp product that was digested with HindIII and MfeI, and the
resulting 83 bp product gel excised and cloned into HindIII
andMfeI digested pLitmus38 (New England Biolabs) result-
ing in pLITSF. Wild-type Ad37, strain GW(76-190026), was
obtained from the American Type Culture Collection
(ATCC), used to infect 911 cells (Fallaux et al., 1996), and
the viral lysate was pronase treated and DNA precipitated
with ethanol. The Ad37 fiber gene (at +49) including 63 bp
upstream of the Ad37 fiber stop codon was PCR amplified
using primers with an EcoRI (underlined) and NdeI site
(bold) FIB17F, cccgaattcatatggctacgcgcggaatc, and FIB17/
37R containing an XbaI site (bold), ccctctagagctggtgtaaaaat-
tcaataaaga; PCR product digested with EcoRI and XbaI, and
cloned into EcoRI and XbaI digested pIRES1neo (Clontech)
resulting in pFIB37pA—a plasmid containing the majority of
the Ad37 fiber gene with its own poly A signal followed by
the bovine growth hormone polyadenylation signal (BGH
pA). The Ad37 fiber and BGH pA were subcloned into
pLITSF, resulting in pFIB37pASF, which was digested with
NdeI and MfeI, and cloned into NdeI and MfeI digested
p6.2FIB, resulting in p6.2FIB37pA. The SpeI to PacI mod-
ified fiber-containing fragment was exchanged with the 6.2-
kb Ad5 fiber-containing fragment in pAdEasy-1, resulting in
pAd5F37 (Fig. 1A). The region containing the modified fiber
gene was confirmed by sequencing. The sequencing data
predicted expression of a 40-kDa fusion fiber protein con-
S.M. Cashman et al. / Virology 324 (2004) 129–139 137sisting of the first 17 amino acids of the Ad5 fiber followed by
amino acids 18–365 of Ad 37 fiber (Fig. 1B). To introduce a
GFP expression cassette into the pseudotyped virus, anAseI–
SspI fragment of pEGFP-C1 (Clontech) was cloned into
EcoRV-digested pShuttle (He et al., 1998), in the antisense
orientation with respect to the E1 enhancer/promoter, result-
ing in pShEGFPN.
Production of recombinant adenovirus
pShEGFPN was digested with PmeI and recombined
with either pAdEasy-1 or pAd5F37 by co-transformation
of Escherichia coli BJ5183 as previously described
(Cashman et al., 2002). The resulting plasmids pEGFP-
NAd5 and pEGFPNAd5F37 were transformed into E. coli
XL1-Blue (Stratagene) for large-scale plasmid amplifica-
tion. The recombinant adenovirus plasmids were digested
with PacI and transfected into 911 cells to generate virus
(Cashman et al., 2002) and purified using the Adenopure
purification kit (Puresyn, Inc) followed by dialysis into
1% sucrose in PBS by centrifugation through a 15-ml
filter device (50 K NMWL; Millipore Corp). Viral preps
were concentrated to a volume of approximately 1 ml
with an A260 of 0.62–1.24. The pseudotyped virus is
hereafter called EGFPNAd5F37 and the control parental
Ad5 based virus as EGFPNAd5.
Cell lines
Chang C, A549, Y79, RPE-J, and CHO (Lec 2) cell lines
were obtained from ATCC. Cell culture reagents were
purchased from Invitrogen Life Technologies. Chang C,
A549, and 911 (Fallaux et al., 1996) cells were maintained
in DMEM and 10% FBS. RPE-J cells were maintained in
DMEM and 4% FBS with 0.1 mM nonessential amino acids.
Y79 cells were maintained in RPMI 1640 with L-glutamine
(2 mM), sodium pyruvate (1 mM), and 15% FBS. CHO
(Lec2) cells were maintained in aMEM with 10% FBS.
Western blots
911 cells were infected at a multiplicity of infection
(MOI) of 250 and 2500 by EGFPNAd5 and EGFP-
NAd5F37, respectively. Thirty-six hours later, cells were
harvested by scraping cells off the culture plate, rinsed
twice with PBS, and lysed in 50 mM Tris–HCl pH 8.0,
150 mM NaCl, 0.1% SDS, 1.0% Triton X-100 containing
leupeptin (10 Ag/ml), aprotinin (10 Ag/ml), and PMSF (0.1
mM). Lysate from EGFPNAd5-infected (5 Ag) or EGFP-
NAd5F37-infected (10 Ag) cells was boiled for 3 min and
loaded onto a 12% Tris-Glycine polyacrylamide gel
(BMA). To determine trimerization of the fiber, samples
were loaded without boiling. The fiber protein was
detected using the monoclonal antibody, Ab-4 (Clone
4D2, NeoMarkers). Secondary detection was performed
using an HRP-conjugated goat anti-mouse antibody (Jack-son ImmunoResearch). For the detection of aV Integrin,
20-Ag protein was electrophoresed as described above.
Integrin (aV) was detected using a monoclonal antibody
specific to amino acids 609–722 of human CD51 (clone
21, BD Transduction Labs). h-Actin was detected using a
monoclonal antibody that detects a 15 amino acid se-
quence at the N-terminus of h-actin (clone AC-15, Sigma).
Secondary detection was achieved with an HRP-conjugat-
ed goat anti-mouse antibody.
Neuraminidase treatment
2.5  105 Chang C or A549 cells were suspended in a
volume of 200 Al (40 mU) Vibrio cholerae neuraminidase
(Sigma) and incubated at 37 jC for 1 h. Cells were washed
with 1 PBS and incubated with virus in DMEM without
FBS at an MOI of 1240 (EGFPNAd5) or 18800 (EGFP-
NAd5F37) at 4 jC for 30 min. The unbound virus was
removed by washing the cells with 1 PBS, and cells were
transferred to 24-well plates for 48 h at 37 jC and 5% CO2.
Different MOIs were used for each virus in this and
successive experiments as use of the same MOI would have
resulted in too little infection by EGFPNAd5F37 or too
much infection by EGFPNAd5.
Lectin blocking
2.5  105 Chang C or A549 cells were suspended in 250
Ag/ml maackia amurensis lectin II (Mal II; Vector Labora-
tories) and incubated at 4 jC for 30 min. Cells were washed
and incubated with virus as described above for neuramin-
idase treatment.
Protease treatment
1  107 Chang C or A549 cells were suspended in 200
Al (40 Ag) proteinase K (Invitrogen), 50 mU bromelain
(Sigma), or PBS, and incubated at 37 jC for 30 min (Chang
C) or 1 h (A549). Cells were washed with 1 PBS and 2.5
105 cells were plated per well of 24-well plates and incubated
with virus in DMEM without FBS at an MOI of 1240
(EGFPNAd5) and 16800 (EGFPNAd5F37) at 37 jC for 6
h. The unbound virus was removed by washing cells with 1
PBS, and the cells were incubated for a further 42 h at 37 jC
and 5% CO2.
Analyses of CAR and sialic acid expression
CAR expression was detected by FACS analysis of cells
incubated with RmcB antibody (provided kindly by Jeffrey
Bergelson) (Hsu et al., 1988) followed by a donkey anti-
mouse antibody conjugated with FITC. Sialic acid was
detected by incubating cells with either FITC-conjugated
wheat germ agglutinin (WGA) or biotinylated Mal II
followed by FITC-conjugated streptavidin (10 Ag/ml; Vec-
tor Laboratories) at 4 jC for 20 min. Cells were fixed with
S.M. Cashman et al. / Virology 324 (2004) 129–1391384% paraformaldehyde and either analyzed by FACS or
visualized directly with a Nikon TS100 microscope with a
short-arc mercury lamp and a FITC filter. Images were
captured using CoolSnap software.
Infection of Y79 and Lec2 cells
2.5  105 cells were suspended in 200 Al RPMI with 2%
FBS (Y79) or aMEM without FBS (Lec2) and infected with
either EGFPNAd5 (MOI of 1240) or EGFPNAd5F37 (MOI
of 12000 or 48000; Fig. 4). Cells were incubated with virus at
37 jC for 1 h, washed, and plated for a further 23-h incubation
at 37 jC and 5% CO2 before FACS analyses.
Transfection of CHO cells with CAR-expressing plasmid
Plasmid-expressing human CAR (hCAR) under the con-
trol of a CMV promoter was kindly provided by Jeffrey
Bergelson. 5 106 CHO (Lec2) cells were mixed with 3.5 Ag
of plasmid expressing beta galactosidase–pCMVh (Clon-
tech) or hCAR and electroporated with 1 pulse of 190 Vover
7ms using an ECM830 (BTX) electroporator. 2.5 105 cells
were plated per well of a 24-well plate. After 6-h incubation at
37 jC and 5% CO2, the cells were infected with either
EGFPNAd5 or EGFPNAd5F37 at an MOI of 2480 and
12800, respectively. The infection was allowed to proceed
for 24 h before FACS analyses.
Effect of EDTA treatment on infection
5  105 RPE-J cells were treated with 2.5 mM EDTA in
PBS at 37 jC for 30 min. Cells were washed with PBS and
incubated with either EGFPNAd5 at an MOI of 1480 or
EGFPNAd5F37 at anMOI of 6400 at 37 jC for 2 h. Unbound
virus was removed by washing the cells with 1 PBS and the
cells were incubated for a further 42 h at 37 jC and 5% CO2
before FACS analyses.
FACS analyses
Cells were harvested with 1 trypsin-EDTA, rinsed, and
suspended in 1 PBS to a concentration of 1  106 cells/
ml. FITC- and EFGP-positive cells were detected using a
FACScan (Becton-Dickinson) equipped with a 15 MW
argon laser (488 nm) activation source and a 530 F 15
nm filter. Results were analyzed using CellQuest Pro
software (Becton-Dickinson).
Statistical analyses
Except where otherwise stated, all experiments were
performed three times in duplicate. Error bars represent
standard deviations from the mean. Positive errors only are
shown. Where absent, error bars were significantly smaller
than the resolution of the graph. Where appropriate, signif-
icance was calculated using the Student’s t test.Acknowledgments
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